However, in contrast to the combination of BRQ and dipyridamole, DHODH inhibition with BRQ did not cause the suppression of proliferation and tumorigenicity of neuroblastoma cell lines when subjected to physiological uridine levels demonstrating again the need for co-targeting pyrimidine salvage. This evidence concerns the gene DHODH and neuroblastoma.